期刊
VIRUSES-BASEL
卷 4, 期 1, 页码 1-27出版社
MDPI
DOI: 10.3390/v4010001
关键词
innate immunity; hepatitis C virus; complement; defensin; pentraxin; collectin; mannose binding lectin; ficolin; pathogenesis; fibrosis
类别
资金
- Medical Research Council [G0801169]
- European Union [MRTN-CT-2006-035599]
- Nottingham Digestive Disease Centre Biomedical Research Unit
- MRC [G0801169] Funding Source: UKRI
Infection with Hepatitis C Virus (HCV) causes chronic disease in approximately 80% of cases, resulting in chronic inflammation and cirrhosis. Current treatments are not completely effective, and a vaccine has yet to be developed. Spontaneous resolution of infection is associated with effective host adaptive immunity to HCV, including production of both HCV-specific T cells and neutralizing antibodies. However, the supporting role of soluble innate factors in protection against HCV is less well understood. The innate immune system provides an immediate line of defense against infections, triggering inflammation and playing a critical role in activating adaptive immunity. Innate immunity comprises both cellular and humoral components, the humoral arm consisting of pattern recognition molecules such as complement C1q, collectins and ficolins. These molecules activate the complement cascade, neutralize pathogens, and recruit antigen presenting cells. Here we review the current understanding of anti-viral components of the humoral innate immune system that play a similar role to antibodies, describing their role in immunity to HCV and their potential contribution to HCV pathogenesis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据